Drug & intervention
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1)
RxCUI 2751877
What this record represents
PIN · RxNormThis is an RxNorm PIN drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/MLSCDC · CureCurrent ID 82009
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/MLSCDC · CureCurrent ID 82003
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML [Comirnaty 2026-2027]SBDC · CureCurrent ID 82011
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML [Comirnaty 2026-2027]SBDC · CureCurrent ID 82006
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.